Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Return on Assets (2016 - 2025)

Historic Return on Assets for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to 5.07%.

  • Outlook Therapeutics' Return on Assets fell 43300.0% to 5.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.07%, marking a year-over-year decrease of 43300.0%. This contributed to the annual value of 1.75% for FY2019, which is 3500.0% down from last year.
  • Outlook Therapeutics' Return on Assets amounted to 5.07% in Q4 2025, which was down 43300.0% from 3.9% recorded in Q3 2025.
  • Outlook Therapeutics' Return on Assets' 5-year high stood at 0.74% during Q4 2024, with a 5-year trough of 5.07% in Q4 2025.